Zai Lab (ZLAB) Capital Expenditures (2018 - 2026)
Zai Lab (ZLAB) posted Capital Expenditures of $1.2 million for Q1 2026, up 76.51% sequentially from $677000.0 in Q4 2025, and down 22.1% YoY from $1.5 million in Q1 2025.
Analysis
Zai Lab (ZLAB) Capital Expenditures (2018 - 2026) Analysis & Trends
Zai Lab has reported Capital Expenditures for 9 years, with the latest figure at $1.2 million in Q1 2026.
- Quarterly Capital Expenditures fell 22.1% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.8 million (up 24.85% YoY) and the FY2025 annual result came in at $8.1 million, up 43.2% from the prior year.
- Capital Expenditures improved to $1.2 million in Q1 2026 per ZLAB's latest filing, from $677000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $9.7 million in Q1 2022 and troughed at $222000.0 in Q4 2023.
- A 5-year average of $2.8 million and a median of $1.8 million in 2023 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2023 and 2024: Capital Expenditures plunged 94.97% in 2023, then soared 1071.17% in 2024.
- Over 5 years, Capital Expenditures stood at $4.4 million in 2022, then slumped by 94.97% to $222000.0 in 2023, then jumped by 1071.17% to $2.6 million in 2024, then tumbled by 73.96% to $677000.0 in 2025, then surged by 76.51% to $1.2 million in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered $1.2 million, $677000.0, and $3.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 37.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 2.29 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 25.02 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 34.68 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 251.02 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.26 Mn |
| 10 | Zai Lab | 2.94 Bn | 2.23 Bn | 58.15 Mn | 1.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.31 Mn |
| Mar 31, 2026 | 1.20 Mn |
| Dec 31, 2025 | 677,000.00 |
| Sep 30, 2025 | 3.01 Mn |
| Jun 30, 2025 | 2.89 Mn |
| Mar 31, 2025 | 1.53 Mn |
| Dec 31, 2024 | 2.60 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 741,000.00 |
| Mar 31, 2024 | 974,000.00 |
| Dec 31, 2023 | 222,000.00 |
| Sep 30, 2023 | 1.76 Mn |
| Jun 30, 2023 | 1.72 Mn |
| Mar 31, 2023 | 3.51 Mn |
| Dec 31, 2022 | 4.41 Mn |
| Sep 30, 2022 | 6.68 Mn |
| Jun 30, 2022 | 3.75 Mn |
| Mar 31, 2022 | 9.74 Mn |
| Dec 31, 2021 | 6.38 Mn |
| Sep 30, 2021 | 6.27 Mn |